The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 03, 2019
Filed:
Jul. 12, 2017
Applicant:
Board of Regents, the University of Texas System, Austin, TX (US);
Inventor:
Vikas Kundra, Missouri City, TX (US);
Assignee:
Board of Regents, The University of Texas System, Austin, TX (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/46 (2006.01); A61K 35/28 (2015.01); A61K 38/17 (2006.01); A61K 38/31 (2006.01); A61K 51/08 (2006.01); C07K 14/71 (2006.01); C12N 15/88 (2006.01); A61K 47/64 (2017.01); A61K 47/69 (2017.01); A61K 51/00 (2006.01);
U.S. Cl.
CPC ...
A61K 47/46 (2013.01); A61K 35/28 (2013.01); A61K 38/179 (2013.01); A61K 38/31 (2013.01); A61K 47/6425 (2017.08); A61K 47/6901 (2017.08); A61K 51/00 (2013.01); A61K 51/083 (2013.01); A61K 51/088 (2013.01); C07K 14/71 (2013.01); C12N 15/88 (2013.01);
Abstract
Methods and composition for cell-based therapy as well as somatostatin receptor-based therapy are described. For example, in certain aspects methods for administering an anti-tumor therapy using a signaling defective somatostatin receptor mutant are described. Furthermore, the invention provides compositions and methods involve a somatostatin constitutively active somatostatin receptor mutant.